Comparing Medium-Term Clinical Outcomes following XEN® 45 and XEN® 63 Device Implantation

PURPOSE: To evaluate medium-term clinical outcomes with XEN® 45 or XEN® 63 Gel Stent (Allergan, Dublin, Ireland) for treatment of primary open angle glaucoma (POAG). Materials and Methods. Retrospective, descriptive, and observational study involving 40 patients implanted with a XEN® 45 Gel Stent an...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-García, Aitor, Zhou, Ying, García-Alonso, Mercedes, Andrango, Henry D., Poyales, Francisco, Garzón, Nuria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125472/
https://www.ncbi.nlm.nih.gov/pubmed/32280523
http://dx.doi.org/10.1155/2020/4796548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125472/
https://www.ncbi.nlm.nih.gov/pubmed/32280523
http://dx.doi.org/10.1155/2020/4796548

Ejemplares similares